Adverse effects of ketoconazole in dogs – a retrospective study
- 8 July 2008
- journal article
- Published by Wiley in Veterinary Dermatology
- Vol. 19 (4) , 199-208
Abstract
Although ketoconazole has been used extensively in dogs for the treatment of various fungal infections, information about adverse effects is mainly anecdotal. Common adverse effects in humans include dose‐dependant anorexia, nausea and vomiting, allergic rashes and pruritus. Drug‐induced hepatitis is very rare, but potentially fatal. The aim of this study was to evaluate the type and frequency of adverse effects associated with ketoconazole therapy in dogs treated for skin diseases and any possible influence of dosage, duration of therapy, signalment or concurrent medication. The medical records of 632 dogs treated with ketoconazole (2.6–33.4 mg/kg) were reviewed. Adverse effects occurred in 14.6% (92 dogs) and included vomiting (7.1%), anorexia (4.9%), lethargy (1.9%), diarrhea (1.1%), pruritus (0.6%), erythema (0.3%) and other adverse effects (2.5%). Of the dogs with other adverse effects, four of 16 (25%) were ataxic and three of these received concurrent ivermectin. Adverse effects were significantly more often recorded in dogs concurrently treated with ciclosporin (P = 0.034) or ivermectin (P = 0.007). Increased liver enzyme levels were reported rarely, and icterus was not seen in any of the dogs. However, monitoring liver enzymes during therapy is recommended, although this might not necessarily prevent severe idiosyncratic hepatotoxicity.Keywords
This publication has 27 references indexed in Scilit:
- Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5Drug Metabolism and Disposition, 2007
- The effects of inhibiting cytochrome P450 3A, p‐glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogsJournal of Veterinary Pharmacology and Therapeutics, 2005
- Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomesXenobiotica, 1998
- Risk/benefit ratio of modern antifungal therapy: Focus on hepatic reactionsJournal of the American Academy of Dermatology, 1993
- Ketoconazole-induced fulminant hepatitis necessitating liver transplantationJournal of the American Academy of Dermatology, 1991
- Mechanism of the ketoconazole-cyclosporin interactionArchives of Toxicology, 1990
- The Use of Ketoconazole as an Inhibitor of Steroid ProductionNew England Journal of Medicine, 1987
- Modification of polymorphonuclear leucocyte function by imidazolesInternational Journal of Immunopharmacology, 1984
- KetoconazoleArchives of Dermatology, 1982
- KetoconazoleDrugs, 1982